ONC

BeOne Medicines Ltd Sponsored ADR · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website -
Employees(FY) -
ISIN US07725L1026

Performance

+0.64%

+21.68%

+8.58%

+42.48%

+21.09%

YTD

+50.89%

Profile

Advanced Technical Analysis

Technical Analysis of ONC 2025-01-31

The stock exhibits a strong bullish sentiment with a Moving Average Score of 90, indicating robust upward momentum, while the Oscillators Score of 40 suggests a neutral stance that may warrant caution. Overall, the Technical Score of 79 reinforces a positive outlook, signaling potential for continued strength in the stock's performance.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ONC

Stock Rank

Recent News & Updates

2025-01-30 04:23
ImmunityBio and BeiGene partner on Phase III trial of NSCLC treatment combo(Clinical Trials Arena)
2025-01-29 09:04
ImmunityBio Partners With BeiGene to Conduct Phase 3 Trial of Lung Cancer Combination Therapy(MT Newswires)
2025-01-23 05:02
Discover 3 US Stocks Including Microchip Technology That May Be Trading Below Estimated Fair Value(Simply Wall St.)
2025-01-22 09:02
Exploring High Growth Tech Stocks in January 2025(Simply Wall St.)
2025-01-20 09:28
When Can We Expect A Profit From BeiGene, Ltd. (NASDAQ:ONC)?(Simply Wall St.)
2025-01-15 15:44
BeiGene Stock Meets 80-Plus RS Rating Benchmark(Investor's Business Daily)
2025-01-15 08:57
BeiGene (ONC) Moves 8.9% Higher: Will This Strength Last?(Zacks)
2025-01-08 17:14
Beigene Insider Sold Shares Worth $7,370,515, According to a Recent SEC Filing(MT Newswires)
2025-01-06 02:00
BeiGene Announces Appointment of Giancarlo Benelli as Head of Europe(Business Wire)
2025-01-05 13:00
BeiGene Announces Appointment of Giancarlo Benelli as Head of Europe(Businesswire)
2024-12-29 17:54
FDA approves BeiGene's TEVIMBRA combo for treating certain gastric cancers(Pharmaceutical-business-review)
2024-12-29 17:42
BeiGenes Tevimbra approved in US for first-line gastric cancer treatment(Yahoo Finance)
2024-12-26 17:00
TEVIMBRA Approved in U.S. for First-line Treatment of Gastric and Gastroesophageal Junction Cancers in Combination with Chemotherapy(Businesswire)
2024-12-22 17:00
BeiGene to Change Nasdaq Ticker Symbol to ONC on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference(Businesswire)
2024-12-12 20:12
BeiGene inks $150M deal to follow cancer combo trail blazed by Amgen and Ideaya(Fiercebiotech)
2024-12-12 06:30
BeiGene Announces Global Licensing Agreement for MAT2A Inhibitor(Businesswire)
2024-12-09 07:30
BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA and Novel Pipeline Assets(Businesswire)
2024-12-03 17:00
BeiGene and CLL Society Partner to Advance Test Before Treat Campaign, Promoting Biomarker Testing to Improve Patient Outcomes in CLL(Businesswire)
2024-12-03 03:00
BeiGene Gains Overweight Rating from Morgan Stanley with $300 Price Target(Yahoo Finance)
2024-12-02 03:08
Why Is BeiGene, Ltd. (BGNE) Among the Best High Growth Healthcare Stocks to Invest In Now?(Yahoo Finance)
2024-12-01 17:01
BeiGene to Host Investor Webcast Highlighting Key Data from ASH and the San Antonio Breast Cancer Symposium on December 16, 2024(Businesswire)
2024-11-26 23:25
BeiGenes PD-1 drug approved in EU for first-line oesophageal cancer treatment(Yahoo Finance)
2024-11-26 23:01
Why Is BeiGene Stock Trading Higher On Wednesday?(Yahoo Finance)
2024-11-26 17:00
European Commission Approves BeiGenes TEVIMBRA for First-Line Treatment of Advanced/Metastatic Esophageal Squamous Cell Carcinoma and Gastric or Gastroesophageal Junction Cancer(Businesswire)
2024-11-25 17:01
BeiGene to Present at Upcoming Investor Conferences(Businesswire)
2024-11-18 18:00
Labcorp CFO Glenn Eisenberg Announces Plans to Retire(Prnewswire)
2024-11-18 17:00
BeiGene Announces Settlement of Litigation Against Generic Filer of BRUKINSA(Businesswire)
2024-11-14 23:20
BeiGene, Ltd. (BGNE): Among 12 High Growth Large Cap Stocks to Buy Now(Yahoo Finance)
2024-11-14 16:00
Halozyme bids for Evotec; BeiGene gets a new name(Yahoo Finance)
2024-11-13 17:00
BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer(Businesswire)

Page 1 of 4

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.